Pulmonx Corporation (LUNG) Insider Trading

Over the last 6 months, 73 institutions increased and 76 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Feb
Mar
Jun
Sep
Dec
Mar
Context3-month price +0.8%Institutions mixed (13F)
DateInsiderTypeSharesPrice
Jun 9, 2026Burns Thomas WilliamdirectorGrant40,000—
Jun 9, 2026Sullivan TiffanydirectorGrant40,000—
Jun 9, 2026Melenikiotou GeorgiadirectorGrant40,000—
Jun 9, 2026Florin Daniel PdirectorGrant40,000—
Jun 9, 2026Ferrari RicharddirectorGrant40,000—
Jun 9, 2026Mead Dana G Jr.directorGrant40,000—
Mar 4, 2026Radhakrishnan Srikanthofficer: Chief Science &Techn. OfficerGrant175,000—
Mar 4, 2026Radhakrishnan Srikanthofficer: Chief Science &Techn. OfficerSell4,198$1.43
Mar 4, 2026Radhakrishnan Srikanthofficer: Chief Science &Techn. OfficerSell756$1.43
Mar 4, 2026Radhakrishnan Srikanthofficer: Chief Science &Techn. OfficerSell2,461$1.43
Mar 4, 2026Radhakrishnan Srikanthofficer: Chief Science &Techn. OfficerSell3,068$1.43
Mar 4, 2026French Glendon E. IIIdirector, officer: President and CEOSell58,368$1.43
Mar 4, 2026French Glendon E. IIIdirector, officer: President and CEOSell2,708$1.43
Mar 4, 2026Lehman David Aaronofficer: GENERAL COUNSELSell4,433$1.43
Mar 4, 2026Lehman David Aaronofficer: GENERAL COUNSELSell2,590$1.43
Mar 4, 2026Lehman David Aaronofficer: GENERAL COUNSELSell1,163$1.43
Mar 4, 2026Lehman David Aaronofficer: GENERAL COUNSELGrant150,000—
Mar 4, 2026French Glendon E. IIIdirector, officer: President and CEOSell6,737$1.43
Mar 4, 2026Lehman David Aaronofficer: GENERAL COUNSELSell4,051$1.43
Mar 4, 2026Rose Geoffrey Beranofficer: CHIEF COMMERCIAL OFFICERGrant100,000—
Mar 4, 2026Rose Geoffrey Beranofficer: CHIEF COMMERCIAL OFFICERSell2,911$1.43
Mar 4, 2026Rose Geoffrey Beranofficer: CHIEF COMMERCIAL OFFICERSell835$1.43
Mar 4, 2026Rose Geoffrey Beranofficer: CHIEF COMMERCIAL OFFICERSell1,861$1.43
Mar 4, 2026Rose Geoffrey Beranofficer: CHIEF COMMERCIAL OFFICERSell2,125$1.43
Dec 9, 2025Florin Daniel PdirectorSell23,321$1.99
Dec 3, 2025Lehman David Aaronofficer: GENERAL COUNSELSell2,176$1.57
Dec 3, 2025French Glendon E. IIIdirector, officer: President and CEOGrant800,000—
Dec 3, 2025French Glendon E. IIIdirector, officer: President and CEOGrant1,200,000—
Dec 3, 2025French Glendon E. IIIdirector, officer: President and CEOSell2,524$1.57
Dec 3, 2025French Glendon E. IIIdirector, officer: President and CEOSell6,281$1.57

Source: LUNG SEC Form 4 filings, latest Jun 9, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their LUNG positions over the last 6 months (SEC Form 13F).

Increased
73
New positions
40
Reduced
76
Sold out
35
Largest moves
InstitutionActionSharesFiled
PRIMECAP MANAGEMENT CO/CA/Reduced4.7MFeb 11, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced4.7MMay 11, 2026
MORGAN STANLEYIncreased4.2MFeb 13, 2026
MORGAN STANLEYReduced4.0MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3.3MMay 15, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.Increased2.8MMay 14, 2026
BLACKROCK, INC.Increased2.7MFeb 12, 2026
BLACKROCK, INC.Reduced2.7MMay 13, 2026
VANGUARD GROUP INCIncreased2.5MJan 29, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.New Position2.0MFeb 12, 2026
EXODUSPOINT CAPITAL MANAGEMENT, LPNew Position2.0MFeb 17, 2026
EXODUSPOINT CAPITAL MANAGEMENT, LPReduced1.9MMay 14, 2026
SILVERCREST ASSET MANAGEMENT GROUP LLCUnchanged1.3MFeb 17, 2026
BANK OF AMERICA CORP /DE/Increased1.2MMay 18, 2026
DEUTSCHE BANK AG\Increased1.2MMay 6, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to LUNG overview (price, financials, earnings)